Cargando…
Innovative In Vitro Chemo-Hormonal Drug Therapy for Refractory Thyroid Carcinomas
More than 95% of the thyroid carcinomas are well differentiated types showing favorable prognosis. However, only a few therapeutic options are available to treat the patients with undifferentiated thyroid carcinomas, especially with refractory thyroid carcinomas that are not amenable to surgery or r...
Autores principales: | Sung, Tae-Yon, Choi, Sung Ho, Lee, Jung Min, Jeong, Jong Ju, Kang, Sang-Wook, Chung, Woong Youn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390719/ https://www.ncbi.nlm.nih.gov/pubmed/22787366 http://dx.doi.org/10.3346/jkms.2012.27.7.729 |
Ejemplares similares
-
Robotic versus Endoscopic Thyroidectomy for Thyroid Cancers: A Multi-Institutional Analysis of Early Postoperative Outcomes and Surgical Learning Curves
por: Lee, Jandee, et al.
Publicado: (2012) -
Diagnosis of parathyroid incidentaloma detected on thyroid ultrasonography: the role of fine-needle aspiration cytology and washout parathyroid hormone measurements
por: Lee, Boeun, et al.
Publicado: (2023) -
Thyroid lobectomy is sufficient for differentiated thyroid cancer with upgraded risk after surgery
por: Choi, Soon Min, et al.
Publicado: (2022) -
Clinical Implications of Age in Differentiated Thyroid Cancer: Comparison of Clinical Outcomes between Children and Young Adults
por: Kim, Kwangsoon, et al.
Publicado: (2022) -
Resistance to Thyroid Hormone with Missense Mutation (V349M) in the Thyroid Hormone Receptor Beta Gene
por: Kim, Ji Yon, et al.
Publicado: (2008)